Colorectal cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Informed consent; 2. Age>=18 years; 3. Diagnosed with colorectal cancer.
Exclusion criteria
Exclusion criteria: 1. Inflammatory bowel disease, acute self-limiting colitis (ASLC), amoebic colitis, ischemic colitis, microscopic colitis, radiation colitis, transflux enteritis, NSAID enteropathy, allergic purple HIV-related intestinal infection, malignant lymphoma and cancer, etc.; 2. PET/CT can show cerebral infarction, patients with mental or neurological diseases, AD or PD and other patients with a clear history of neurological diseases; and other related diseases that may affect brain metabolic scintigraphy; 3. Pregnant or lactating patients; 4. Is participating in another clinical study; 5. Poor compliance; 6. Any condition that, in the opinion of the investigator, may result in the inability of the patient to complete the study, including but not limited to cardiovascular disease (NYHA IV, recurrent ventricular arrhythmia) or non-cardiovascular disease (e.g., malignancy other than basal cell carcinoma, liver cirrhosis, chronic lung disease, severe autoimmune disease) that may result in death within 3 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumour recurrence;Tumour metastasis;Death; | — |
Countries
China
Contacts
The First Affiliated Hospital of Zhengzhou University